EP3429546A1 - Procédé pour élaborer une préparation médicinale - Google Patents

Procédé pour élaborer une préparation médicinale

Info

Publication number
EP3429546A1
EP3429546A1 EP17710921.2A EP17710921A EP3429546A1 EP 3429546 A1 EP3429546 A1 EP 3429546A1 EP 17710921 A EP17710921 A EP 17710921A EP 3429546 A1 EP3429546 A1 EP 3429546A1
Authority
EP
European Patent Office
Prior art keywords
peristaltic pump
target container
liquid
container
pump
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP17710921.2A
Other languages
German (de)
English (en)
Other versions
EP3429546B1 (fr
Inventor
Martin Biehl
Michael Hock
Henrik SCHAAKE
Ulla Schöbel
Martin Bohm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi Deutschland GmbH
Original Assignee
Fresenius Kabi Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Deutschland GmbH filed Critical Fresenius Kabi Deutschland GmbH
Priority to EP23168051.3A priority Critical patent/EP4218709A1/fr
Publication of EP3429546A1 publication Critical patent/EP3429546A1/fr
Application granted granted Critical
Publication of EP3429546B1 publication Critical patent/EP3429546B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/002—Compounding apparatus specially for enteral or parenteral nutritive solutions
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B43/00—Machines, pumps, or pumping installations having flexible working members
    • F04B43/12—Machines, pumps, or pumping installations having flexible working members having peristaltic action
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00—General characteristics or adaptations
    • A61J2200/70—Device provided with specific sensor or indicating means
    • A61J2200/74—Device provided with specific sensor or indicating means for weight

Definitions

  • the invention relates to a method and a plant for producing a medical preparation.
  • the invention relates to a method by which infusion bags and / or syringes are filled for parenteral nutrition, as well as an associated facility.
  • Preparations for parenteral nutrition are produced for example in pharmacies or clinics patient-specific. These are mixtures of different Basic foods, trace elements and vitamins, possibly also together with a medicine, which are individually transferred into an infusion bag.
  • TPN Total Parenteral Nutrition
  • the safety requirements for producing such medical preparations are high.
  • a high accuracy of the dosage of all components should be ensured.
  • To check the dosage of the target container can be weighed.
  • the medicinal preparations to be prepared comprise components with main constituents such as water, fat, sugar and amino acids, which are added in quite a large amount.
  • main constituents such as water, fat, sugar and amino acids
  • Such components are also referred to as micro quantities.
  • the invention is the object of the invention to provide a method for producing a medicinal preparation, in which by means of a peristaltic pump accurate dosing of the individual components of a medical preparation is possible and in which a precise check of the dosage is possible.
  • the invention relates to a method for producing a medicinal preparation, in particular the invention relates to a method for producing a preparation for parenteral nutrition.
  • liquids are taken from a plurality of source containers and transferred with a peristaltic pump into a target container.
  • the peristaltic pump is a positive displacement pump in which the medium to be delivered is forced through the hose by external mechanical deformation of a hose.
  • the peristaltic pump preferably has a pump wheel with rollers, with which the hose is compressed.
  • the preparation of the medical preparation is automated, wherein the user of the system used for the process can enter the desired composition in the target container or this can select from a database with a plurality of recipes.
  • metering step a defined amount of liquid is withdrawn from the individual source containers, hereinafter also referred to as "metering step.” After completion of all metering steps provided for a target container, by definition a “filling process" is completed.
  • such a medicinal preparation consists of main components which are supplied in greater quantity, and so-called “micro amounts", which may in particular contain vitamins, minerals or pharmaceutical components.
  • a transfer set designed as a disposable component is preferably used, which comprises the tube which is inserted into the peristaltic pump.
  • the transfer set also includes connection tubes for the source containers as well as a connection for the destination container.
  • the transfer set preferably comprises a valve unit, by means of which the connections to the individual source containers can be opened and closed.
  • a single valve which leads to a source container, is opened during each individual metering step. So it is always removed only one source container liquid.
  • each preparation contains a so-called universal liquid, also called “Universal Ingredient” (Ul) .
  • This fluid may come into direct contact with any other ingredient without undesirable side effects and is used in every preparation
  • the universal fluid is mostly isotonic water
  • the target container is weighed at preferably every single dosing step and thus the amount of transferred into the target container Checked liquid at every single dosing step.
  • all dosing steps are checked by weighing the target container, ie also the dosing steps of micro quantities of less than 10 ml, preferably of less than 5 ml, more preferably of less than or equal to 3 ml.
  • the preferred embodiments of the invention described below relate to measures to increase the dosing accuracy and / or the accuracy in the review of the individual dosing steps.
  • the peristaltic pump used for the method has a region with a linear characteristic and a region with a non-linear characteristic of the pump power.
  • An area with a linear characteristic is understood to mean the angular range of a pump wheel, in which the pump power, that is, the volume relative to the pump Angle of rotation of a pump wheel of the peristaltic pump, is constant.
  • the volume delivered is proportional to the angle of rotation.
  • suction-side linear area This is the area in which a suction-side roll of the peristaltic pump is engaged with the hose and no roll re-engages the hose.
  • the angle of rotation is proportional to the volume delivered on the intake side.
  • rollers of the impeller go into engagement and out of engagement at other phase angles. At least one roller is engaged at any one time, the pump is never "open.”
  • a roller pump therefore theoretically has no slippage, ie no deviation between the angle of rotation and the delivered quantity.
  • a review of each dosing step is improved according to an embodiment of the invention, even at micro quantities, that the amount of a Dosing step in the target container transferred liquid is calculated taking into account the pressure-side characteristic of the pump power of the peristaltic pump.
  • the target container is weighed, thus checking the amount of each transferred liquid. For this check based on the weight of the target container according to this embodiment of the invention but not the calculated amount of the source container withdrawn amount of liquid used, but it is calculated taking into account the pressure-side characteristic of the peristaltic pump, which amount of liquid was transferred to the target container.
  • the user of the system for example by display on a display, be prompted to discard the target container and fill a new target container and / or to calibrate the system.
  • the amount of liquid to be taken from the respective source container is used to calculate the required rotation of the pump wheel on the basis of the suction-side characteristic curve of the peristaltic pump.
  • the amount of liquid taken from the respective source container can be calculated calculated at each dosing step.
  • the pump is thus controlled and the required angle of rotation is calculated for a dosing step.
  • the dosage and thus in the control of the peristaltic pump at each dosing is not assumed in this embodiment of the invention of a constant flow rate, but it is based on a previously determined and stored characteristic, the suction side existing fluctuation of the pump power is calculated, which improves the dosing accuracy.
  • the peristaltic pump for metering from at least one source container is brought into a position such that the entire metering from this source container takes place in a region with a linear characteristic.
  • This embodiment of the invention is based on the finding that the dosage of micro quantities is also possible with a peristaltic pump with high accuracy if during the entire metering step the peristaltic pump is moved exclusively in the region with a linear characteristic.
  • the amount of liquid to be metered in this metering step must be so small that the entire liquid to be dispensed can be promoted in an angular range of the impeller of the peristaltic pump by this does not leave the linear range.
  • the peristaltic pump preferably comprises a rotary encoder.
  • the peristaltic pump is brought into a position in which the suction-side characteristic of the peristaltic pump is linear.
  • the linear region of the peristaltic pump present on the suction side is used in order to dose the withdrawn amount as precisely as possible.
  • liquid can be taken from a source container other than that from which the metering is to take place.
  • a swelling container having the above-described universal liquid (Ul) can be used. While the pump operates in the non-linear range, so medium is taken from the source container with universal fluid.
  • the peristaltic pump can be operated in a conventional manner, ie during the respective metering step, both the non-linear and the linear region of the suction and / or pressure-side characteristic of the peristaltic pump.
  • the sequence of different liquids in the inlet of the target container is taken into account in order to include the density of the liquids during the checking during weighing.
  • This embodiment of the invention is based on the recognition that the accuracy of the check is increased at each dosing step by taking into account the density, ie the specific weight of the respective liquid transferred to the target container.
  • the liquid in the dosage of micro quantities, it may be that after removal of a predetermined amount of liquid from a source container, the liquid does not arrive directly in the target container, but is initially in the transfer set, for example, in the tube inserted in the hose pump.
  • the liquid that is in front of this liquid in the transfer set and that is now pressed into the target container may have a different density. Therefore, only the weight gain of the target container can not be used as a sufficiently accurate measure of the transferred amount.
  • the inlet of the target container is subdivided into sections, each containing liquid of a different density.
  • This principle is based on the consideration that all liquids taken from the source containers ultimately arrive in the target container. Since the volume of the distance from the source container or from the valve, from which the liquid of the respective source container flows into the valve unit, to the source container located on the balance is known, it can be calculated which liquid or which liquids arrives at a dosing in the target container or Arrive.
  • the volume is determined by the valve unit from the position of the respective valve of the source container, and the guided through the hose pump hose connecting the valve unit with the target container.
  • the density of the introduced liquid may differ at least at the beginning of the metering step.
  • the liquids arranged in an inlet and / or in a hose of the peristaltic pump are not exactly separated from one another according to this calculation model, but rather that different liquids are mixed in the area of the boundary surface.
  • these mixing effects can be neglected in general or in an approximation.
  • dosing micro quantities it can also lead to occlusions that are difficult to detect on the system side. For example, if the hose leading from a source container to the peristaltic pump is clogged, the peristaltic pump will still deliver fluid to the target container at a small amount, especially less than 3 ml since the flexible tubing of the transfer set may contract.
  • the delivery rate of the peristaltic pump is therefore checked by means of a flow sensor.
  • the flow sensor is arranged on the suction side.
  • a flow sensor may be provided in which a hose of the transfer set is inserted.
  • Such flow sensors are known. It has been found that these are not suitable for accurately determining the flow rate even at very low flow rates. In the case of a blockage or in the case of a non-opening valve of the transfer set such a high deviation from a setpoint can be determined via the flow sensor, however, that it can be concluded that the flow rate to the current theoretical flow rate of the pump is not plausible.
  • the procedure can then be aborted and the user of the system informed about an error message.
  • a bubble sensor (Bubble Detector) is used to check in an inlet in the target container that no bubbles are conveyed in the hose
  • This bubble sensor which may for example be designed as an ultrasonic sensor, is preferably located on the pressure side to the peristaltic pump. It is in particular a sensor in which the tube of a transfer set can be inserted.
  • the procedure may also be stopped and the user informed of an error message.
  • the metering factor of the peristaltic pump is determined in an upstream calibration step by weighing a target container.
  • the metering factor is the volume which is conveyed when delivering a certain liquid, in particular when pumping water, at a certain speed of the impeller and at a full pump revolution.
  • the metering factor depends, among other things, on tolerances of the hose inserted into the pump. This metering factor can be calibrated during commissioning of the system when filling a target container in order to adapt the activation of the peristaltic pump to a newly used transfer set.
  • waste bag when commissioning the plant for producing the medical preparation, a first target container is used, which is subsequently discarded, a so-called "waste bag.”
  • This waste bag is connected by means of the transfer set and they become the ones venting all leading hoses leading tubes, each by a required amount of liquid is removed.
  • liquid preferably water
  • this metering factor is used for the calculation of the pumped by the pump at further dosing steps amount.
  • the metering factor is in turn to be set in relation to the above-described consideration of the non-linear region of the suction-side and pressure-side characteristic of the peristaltic pump.
  • the pumping capacity of a peristaltic pump depends inter alia on the medium to be delivered, in particular on the viscosity of the liquid to be delivered. This dependence can, as it is provided in one embodiment of the invention, also be taken into account in the calculation of the quantities delivered.
  • a flow factor of 1, 0 can be used, for other media, such as glucose, this flow factor takes on higher values, for example values up to 1, 1. This can be taken into account in the calculation of the quantities produced, in particular the quantities of main components produced, by including the flow factor in the calculation of the volume delivered.
  • Another aspect of the invention relates to a method for producing a medical preparation, wherein a liquid is transferred from a plurality of source containers by means of a peristaltic pump in a target container.
  • the metering factor of the peristaltic pump is calibrated.
  • the invention thus provides that the metering factor of the peristaltic pump is not only determined initially when the system is put into operation, but that, if possible, the metering factor is also checked during regular operation of the system, ie during the manufacture of medical preparations, and possibly new is calibrated. It is provided in particular that, in addition to an initial calibration by determining the metering factor, there are a plurality of, preferably at least three, further determinations of the metering factor during the duration of use of a transfer set. Preferably, this in-service calibration is performed when a sufficient amount of universal liquid or water is transferred to the target container since the flow factor of this general liquid is always 1.0 so that no error due to a different flow factor is included in the calibration.
  • the calibration during operation is preferably carried out with delivery of the same liquid as was used to initially determine the metering factor using the waste bag.
  • the calibration is made during operation only when the transfer set is flushed with universal fluid, the inlet of the target container thus has no sections in which another liquid is.
  • a plant for producing a medicinal preparation in particular a plant for the production of parenteral nutrition, comprising a peristaltic pump and a system for carrying out a method according to the invention described above.
  • Fig. 1 shows a perspective view of a plant for the preparation of a medicinal preparation, as used for the inventive method.
  • Fig. 2 is a detail view of the peristaltic pump.
  • FIG. 3 the characteristic of a peristaltic pump will be explained with reference to an embodiment.
  • 4a to 4c are detailed views of the valve unit of the plant for the preparation of a medical preparation together with hoses.
  • FIGS. 5a and 5b show, with reference to a flowchart, the method steps in an exemplary embodiment of the method according to the invention.
  • Fig. 6 is a detail view of the plant for preparing a medical preparation, in which flow sensor and bubble sensor can be seen.
  • Fig. 7 is a schematic representation of the inflow of the target container, on the basis of which the calculation of the amount transferred to the target container will be explained.
  • Fig. 8 is a flowchart for explaining the check of each metering step by weighing the target container.
  • Fig. 9 is a flow chart for explaining the calculation of the weight of the liquid transferred to the target container.
  • FIG. 10 is a flow chart for explaining control of the bubble sensor.
  • FIG. 11 is a flow chart to explain control of the flow sensor.
  • Fig. 1 shows a plant 1 for the preparation of a medical preparation.
  • the plant 1 for the production of a medical preparation comprises a plurality of source containers 2, which are only partially shown in this view.
  • those source containers are not shown, which comprise the main components of the medicinal preparation, as well as the container which is filled with universal liquid.
  • these containers can be remotely remote, e.g. be hung on a hook attached to a rail.
  • an infusion bag target container 3 which is arranged on a balance 4. Through the balance 4, the amount of liquid transferred to the target container 3 can be checked during operation of the system 1.
  • a transfer set which comprises a valve unit 5 and hoses 14, 15, with which the valve unit 5 is connected to the one with the target container 3 and the other with the source containers 2.
  • valve of the valve unit 5 is opened via the system 1 in each case during a dosing step, so that liquid can be pumped from exactly one source container 2 into the target container 3.
  • the plant 1 here has a single peristaltic pump 6, by means of which liquids from all the source containers 2 can be pumped into the target container 3.
  • the system 1 further has a display 7, which is designed for example as a touch screen, by means of which the user can program the system 1, and in particular can select a program by means of which a target container 3 is filled with a predetermined composition of components.
  • the system includes an electronic control (not shown), via which the peristaltic pump 6 is controlled and which is connected to the balance 4.
  • Fig. 2 is a detail view of the peristaltic pump 6.
  • the pump 6 is here preferably provided as a roller pump.
  • the peristaltic pump 6 has an impeller 8 with two rollers 9.
  • the tube to be inserted is not shown in this view. It is understood that the method according to the invention can also be carried out with a peristaltic pump with a different number of rollers, in particular with a peristaltic pump comprising three rollers (not shown).
  • the hose pump has an inlet 10 and an outlet 11. In the position of the impeller 8 shown here, both rollers 9 are in engagement with the hose.
  • the amount of the delivered liquid in a full revolution between 5 and 50 ml.
  • the peristaltic pump 6 is moved by turning the impeller 8 into a position in which the respective micro quantity is completely metered in the at least suction side linear region of the peristaltic pump 6 can be.
  • the peristaltic pump comprises a rotary encoder (not shown).
  • phase angle p is divided into 1600 units, which are plotted on the x-axis. These 1600 steps represent one complete revolution of the pump.
  • the differential flow, ie the volume delivered per rotation angle unit, for the peristaltic pump 6 is plotted on the y-axis.
  • the dashed curve represents the pressure-side differential flow and the dotted curve represents the suction-side differential flow.
  • the burglaries are in the areas where a roll goes out of engagement.
  • the hose of the hose pump returns to its original shape.
  • the hose increases its volume and the delivery rate of the pump is reduced on the pressure side.
  • the funded volume of the suction side is relevant. All liquid that is removed in the respective dosing step the source container, finally reaches the target container. It is therefore crucial that in each dosing step, the correct volume is taken from the suction side.
  • the peristaltic pump in a dosing step, liquid is now conveyed only in one of the two linear regions of the suction side of the pump.
  • the suction-side characteristic of the peristaltic pump is used according to another aspect of the invention to more accurately calculate the amount of liquid taken from the source container.
  • the suction-side characteristic of the peristaltic pump can be used to calculate the quantities of the withdrawn liquid.
  • the phase angle p2 is determined, so that
  • Vs is the volume to be taken from the source container.
  • the pressure-side characteristic curve of the pump can in turn be used to check in an improved way by weighing the target container, if the actually taken amount corresponds to the calculated quantity.
  • the volume of liquid entering the target container is calculated.
  • the mass of the is calculated.
  • the characteristic Dd of the pressure side is used.
  • the characteristics preferably determined by empirical measurements may e.g. stored as approximate formulas or as a simple value table to calculate the suction and pressure side pumping power as a function of the phase angle.
  • the characteristics can be determined by measurement and then approximated by an empirical formula. The calculations in the plant then take place using the empirical formula or a table of values.
  • FIG. 4a is a perspective view of the valve unit 5 used for the plant for manufacturing a medical preparation.
  • the valve unit 5 comprises a plurality of inlets 12, which are connected via hoses 15 with the source containers (2 in Fig. 1).
  • a hose 15 By way of valves (not shown) integrated in the valve unit 5, a hose 15, by means of which fluid is withdrawn from a source container, can be selectively connected to a hose 14 which is arranged on the outlet 13 of the valve unit 5.
  • the hose 14 further includes a portion which is inserted into the hose pump.
  • Fig. 4b the ends of the tubes 15 are shown for connection of the source container.
  • the connections 22 for the source containers which are formed in this exemplary embodiment as a Luer lock connection with a connected spike.
  • Fig. 4c shows the hose 14, which forms the outlet of the valve unit 5 and at the same time the inlet of the target container. You can see the connection 23 for the target container.
  • This transfer set is preferably designed as a disposable component and is replaced regularly. Due to this configuration, the come to transferring liquids on the way from the source container to the target container only with components of the transfer set in contact.
  • a so-called "waste bag” is inserted as a target container, that is, a container which is not intended to be used as intended for applying a medical preparation, but which is discarded after preparing the system.
  • the metering factor of the peristaltic pump can be determined by weighing the waste bag when pumping universal fluid. The changing due to particular tolerances of the hose used pumping power of the peristaltic pump is now calibrated by determining this metering factor.
  • the waste bag is then discarded and the first target container, which is to be filled with a medicinal preparation, can be connected.
  • step 5 the impeller is spent in an area with suction side linear characteristic, wherein during the introduction of the impeller in this position initially universal fluid is conveyed.
  • a micro amount can be completely removed in the suction side linear region of the characteristic of the pump to the source container.
  • Each individual dosing step, including the step of dosing a micro amount, is checked by weighing the target container.
  • the density of the liquid transferred into the target container is taken into account by calculating which liquid or which liquids are located in the feed of the target container during transfer of the micro amount in step 5 and are transferred into this.
  • the arithmetic check of the source container taken for a main component amount is made taking into account the density of the transferred into the target container liquid and taking into account the pressure-side characteristic of the peristaltic pump.
  • a flow factor which is dependent on the type, in particular on the viscosity, of the pumped liquid is also a further factor in the calculation of the volume of the conveyed liquid.
  • Water is assigned a flow factor of 1.0, with viscous components such as glucose solutions, the flow factor changes significantly. It has been shown that a general consideration of the flow factor is sufficient in dependence on the liquid taken out in each dosing step, since a viscosity-related influence of the pumping capacity is present primarily due to the constriction present at the connection of the source container (eg spike).
  • Vs is the volume to be dosed during a dosing step. This corresponds to the volume of the suction side to which a source container is connected.
  • p1 is the position of the impeller before the metering step, in particular the end position of a previous metering step or the beginning of the linear range in which the impeller has been previously rotated.
  • p2 is the calculated position of the impeller after the dosing step, ie the result of the calculation for the rotational angle of the pump in the dosing step.
  • F is the flow factor, ie the correction factor for the respective viscosity of the medium.
  • Ds (p) is the characteristic of the suction side (constant) and p is the phase of the pump impeller.
  • the phases p1 and p2 can differ by several revolutions.
  • the flow factor F is thus a correction for an additional slip of the pump by water increased viscosity.
  • the volume to be dispensed is in particular set higher by a factor of F than in the case of water.
  • This calculated weight is used to check the respective dosing step via weighing.
  • Vd is the volume expected on the pressure side, ie the volume of liquid which is conveyed in the dosing step into the target container located on the balance.
  • Dd (p) is characteristic of the pressure side (constant).
  • the flow factor F is not included in the calculation of the volume delivered on the pressure side, since the "slip of the pump is not conveyed.
  • the expected mass increase G on the balance is then:
  • G Vd * p with the density P of the pumped medium.
  • P is therefore the specific weight of the liquid transferred to the target container during a dosing step, ie, first of all the liquid already present in the feed of the target container. If several different liquids are transferred to the target container during a dosing step, the specific weight of the liquids is set in relation to their quantity. As a next step, additional micro quantities or further main constituents are fed in further metering steps. Steps 5 to 9 can therefore be repeated until all the desired components are in the target container.
  • the steps 5. to 7. So the dosage of a micro amount, as well as the steps 8 and 9, so the dosage of a main component, are also interchangeable, so can be made in different order.
  • the transfer set is rinsed with universal liquid and, if appropriate, the desired residual quantity of universal liquid is fed to the target container.
  • this rinsing phase in which the impeller of the peristaltic pump rotates by more than one full revolution, in order to redetermine the dosing factor of the peristaltic pump during operation by weighing the target container.
  • the dosing factor can thus be recalibrated during operation. This can change, for example, by the fact that the elasticity and shape of the tube inserted into the peristaltic pump changes.
  • the target container After completion of all dosing steps and rinsing of the transfer set, the target container can be removed and a new target container can be connected.
  • FIG. 6 is a further detailed illustration of FIG. 1.
  • FIG. To recognize is in turn the target container 3. Further to recognize is a valve unit. 5
  • the hose not shown here, which connects the valve unit 5 with the target container 3, and which is inserted in particular into the peristaltic pump, is first inserted into a flow sensor 16.
  • the suction-side flow in the hose is measured and the flow rate of the peristaltic pump can be checked for plausibility. If, for example, there is a blockage in the area of the valve unit or at the connection of a source container, the suction-side flow rate will decrease in such a way that an error can be detected by means of the flow sensor 16. In particular, when dosing a micro amount, the tube will first contract also in the area of the flow sensor 16, with the result that the detected flow can be reduced and a blockage can be concluded. The electronic control can then generate an error message and be displayed to the user.
  • the flow sensor 16 is preferably designed as an ultrasonic sensor. In particular, at low flow rates, such a sensor is generally not accurate enough to be able to determine the amount of the suction side funded fluid alone sufficiently accurate via the flow sensor.
  • the flow sensor is used solely to control such that when exceeding a threshold value of the difference of calculated capacity of the peristaltic pump and resulting calculated flow rate against the flow rate determined by the flow sensor, an error is assumed.
  • the tube On the pressure side, the tube is inserted into a bubble sensor 17. It is an ultrasonic sensor that detects bubbles and shuts off the system above a certain threshold and indicates an error to the user.
  • FIG. 7 is a schematic illustration of the hose 14 connecting the valve unit 5 to the target tank 3.
  • three series-connected valve units are shown, but this has no influence on the basic principle.
  • the three valve units 5 shown here can just as well be combined to form a single valve unit.
  • valve unit 5 By means of the valve unit 5, the feed to a source container is opened at each dosing step, so that liquid from the source container via the respective valve of the valve unit can first enter the valve unit and then into the hose 14.
  • the tube 14 and the collecting channels 22 of the valve units 5 form a volume into which the liquid taken from the respective source containers is first transferred.
  • the density of the liquid withdrawn during the respective metering step is not taken as the basis.
  • the tube 14 and the collecting channels 24 of the valve units 5 are considered such that different liquids, namely a first liquid 19, a second liquid 20 and a third liquid 21 in different sections of the tube 14 and / or the subsequent collecting channel 24 are. If, for example, a micro amount is metered in, the specific weight of the first liquid 19 is initially taken as the basis. This theoretical "material stack" can improve the accuracy of the verification. In particular, it is possible to check and evaluate each individual dosing step.
  • Fig. 8 is a flowchart for explaining the check of each metering step by weighing the target container.
  • the weight transferred to the target container is calculated as a target weight. This is done, as described above, based on the pressure-side characteristic of the peristaltic pump and the specific gravity of the liquid transferred to the target container.
  • the filling process is aborted and an error message is issued , The user can then correct the error if necessary, insert a waste bag and recalibrate the systems.
  • the filling process is continued.
  • Fig. 9 is a flowchart for explaining the calculation of the target weight in a metering step.
  • the volume of the liquid introduced is calculated on the basis of the pressure-side characteristic of the peristaltic pump.
  • the specific weight of the transferred liquid or liquids can then be used to calculate the target weight.
  • This target weight serves to determine the limit values mentioned in FIG. 8.
  • a first limit range could be defined as a deviation of over 10% and a second limit range as a deviation above 5%.
  • boundary regions can also be varied depending on the liquid withdrawn in a dosing step, since there are components in which deviations in the amount are more or less critical to the quality of the medicinal preparation.
  • Fig. 10 is a flow chart for explaining control of the bubble sensor.
  • the amount of bubbles in the transferred liquid is about the arranged after the hose pump bubble sensor is continuously monitored.
  • two border areas are provided.
  • the filling process is interrupted and an error message is issued. If a second, narrower limit range is not adhered to, the filling process can continue and the target container can be used as intended, but when the filling process is completed an error message appears indicating that the system must be bled.
  • next target container can be inserted after completing the filling process
  • FIG. 11 is a flow chart to explain control of the flow sensor.
  • the flow rate is calculated continuously, preferably on the basis of the suction-side characteristic of the peristaltic pump. In parallel, the flow rate is measured with a flow sensor located upstream of the peristaltic pump.
  • Measured and calculated flow rates are compared. If there is a deviation above a threshold, in this example 20%, an error (e.g., occlusion) is closed and the filling process is aborted.
  • a threshold in this example 20%
  • An error message informs the user.
  • any error message to indicate to the user the source container (e.g., via a number on a screen) from which liquid was withdrawn upon fault entry.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)
  • Loading And Unloading Of Fuel Tanks Or Ships (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un procédé et une installation pour élaborer une préparation médicinale, une pompe péristaltique étant utilisée pour acheminer un liquide à partir d'une pluralité de contenants sources. Selon l'invention, les différentes étapes de dosage sont contrôlées par pesée, le dosage de micro-quantités pouvant également être contrôlé.
EP17710921.2A 2016-03-15 2017-03-15 Procede de fabrication d'une preparation medicamenteuse Active EP3429546B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP23168051.3A EP4218709A1 (fr) 2016-03-15 2017-03-15 Procede de fabrication d'une preparation medicamenteuse

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16160323 2016-03-15
PCT/EP2017/056137 WO2017158032A1 (fr) 2016-03-15 2017-03-15 Procédé pour élaborer une préparation médicinale

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP23168051.3A Division EP4218709A1 (fr) 2016-03-15 2017-03-15 Procede de fabrication d'une preparation medicamenteuse

Publications (2)

Publication Number Publication Date
EP3429546A1 true EP3429546A1 (fr) 2019-01-23
EP3429546B1 EP3429546B1 (fr) 2023-04-19

Family

ID=55646294

Family Applications (2)

Application Number Title Priority Date Filing Date
EP23168051.3A Pending EP4218709A1 (fr) 2016-03-15 2017-03-15 Procede de fabrication d'une preparation medicamenteuse
EP17710921.2A Active EP3429546B1 (fr) 2016-03-15 2017-03-15 Procede de fabrication d'une preparation medicamenteuse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP23168051.3A Pending EP4218709A1 (fr) 2016-03-15 2017-03-15 Procede de fabrication d'une preparation medicamenteuse

Country Status (6)

Country Link
US (1) US10966906B2 (fr)
EP (2) EP4218709A1 (fr)
CN (1) CN108778228B (fr)
ES (1) ES2945413T3 (fr)
PL (1) PL3429546T3 (fr)
WO (1) WO2017158032A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3795132B1 (fr) * 2016-03-15 2024-08-21 Fresenius Kabi Deutschland GmbH Équipement pour fabriquer une préparation médicale
US11846279B2 (en) 2021-01-29 2023-12-19 Masterflex, Llc Accurate volume dispensing using pump and flow sensor
US11920581B2 (en) 2021-01-29 2024-03-05 Masterflex Llc Flow rate control for pump with flow sensor
AU2023232562A1 (en) 2022-03-08 2024-09-05 Equashield Medical Ltd Fluid transfer station in a robotic pharmaceutical preparation system

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0112356B2 (fr) * 1982-06-24 1995-12-27 Baxter Travenol Laboratories, Inc. Dispositif de communication de fluide
US4513796A (en) * 1982-06-24 1985-04-30 Baxter Travenol Laboratories, Inc. High speed bulk compounder
US4473173A (en) * 1983-01-10 1984-09-25 Applied Color Systems, Inc. Apparatus and method for low volume dispensing
US4718467A (en) 1986-05-30 1988-01-12 Baxter Travenol Laboratories, Inc. Pumping module arrangement and manifold
US5228485A (en) * 1986-12-08 1993-07-20 Clintec Nutrition Co. Flexible tubing occlusion sensor
US5040699A (en) * 1989-05-15 1991-08-20 Gangemi Ronald J Fluid compounding method and apparatus
DE3938898A1 (de) 1989-11-24 1991-05-29 Sartorius Gmbh Verfahren und vorrichtung zum pulsationsfreien kontinuierlichen gravimetrischen dosieren
US5697407A (en) * 1995-11-30 1997-12-16 The Metrix Company Compounding system for multiple chamber receptacles
US5927349A (en) * 1996-12-09 1999-07-27 Baxter International Inc. Compounding assembly for nutritional fluids
US6199603B1 (en) * 1998-08-14 2001-03-13 Baxter International Inc. Compounding assembly for nutritional fluids
US6975924B2 (en) * 1999-12-03 2005-12-13 Baxter International Inc. Method and apparatus for controlling the strategy of compounding pharmaceutical admixtures
US7317967B2 (en) * 2001-12-31 2008-01-08 B. Braun Medical Inc. Apparatus and method for transferring data to a pharmaceutical compounding system
US7645127B2 (en) * 2003-04-29 2010-01-12 Loren Hagen Pulseless peristaltic pump
US7555437B2 (en) * 2006-06-14 2009-06-30 Care Cam Innovations, Llc Medical documentation system
US20090154764A1 (en) * 2006-10-20 2009-06-18 Forhealth Technologies, Inc. Drug vial detection in an automated drug preparation system
EP2347129A4 (fr) * 2008-11-10 2016-08-31 Curlin Medical Inc Procédé et appareil pour pompe péristaltique
JP5490140B2 (ja) * 2009-10-14 2014-05-14 パナソニック株式会社 薬液調製支援システムおよび薬液調製支援方法
US10549248B2 (en) * 2015-04-23 2020-02-04 B. Braun Medical Inc. Compounding device system, software and method for controlling the process of compounding admixtures
US11357966B2 (en) * 2015-04-23 2022-06-14 B. Braun Medical Inc. Compounding device, system, kit, software, and method
CN104912786B (zh) * 2015-06-05 2017-03-01 深圳市清时捷科技有限公司 一种移液泵校准装置及校准方法

Also Published As

Publication number Publication date
US10966906B2 (en) 2021-04-06
PL3429546T3 (pl) 2023-07-17
EP3429546B1 (fr) 2023-04-19
WO2017158032A1 (fr) 2017-09-21
ES2945413T3 (es) 2023-07-03
US20190070074A1 (en) 2019-03-07
EP4218709A1 (fr) 2023-08-02
CN108778228B (zh) 2022-01-14
CN108778228A (zh) 2018-11-09

Similar Documents

Publication Publication Date Title
DE102011106113B4 (de) Verfahren und Vorrichtung zum Überprüfen der Förderleistung mindestens eines ersten und eines zweiten Fördermittels einer Vorrichtung zur extrakorporalen Blutbehandlung
EP3429546B1 (fr) Procede de fabrication d'une preparation medicamenteuse
EP2717938B1 (fr) Procédé et dispositif de détermination d'au moins un paramètre de fonctionnement d'un dispositif de traitement extracorporel du sang dépendant de la pression absolue, dispositif de traitement extracorporel du sang
DE69636744T3 (de) System zur Infusion einer Mehrzahl von Lösungen in die Bauchhöhle eines Patienten
EP3953058B1 (fr) Dispositif d'application et procédé d'application correspondant
DE2754894C2 (de) Vorrichtung zum Bilanzieren einer einem Patienten entnommenen Flüssigkeit mit einer Ersatzflüssigkeit
EP2349405B1 (fr) Dispositif de détermination d'au moins un paramètre d'écoulement
DE4437597B4 (de) Verfahren zum Auswiegen von Inhaltsstoffen in Kapseln und Vorrichtung zum Dosieren von Inhaltsstoffen
DE3329977A1 (de) Vorrichtung zur dosierten gleichzeitigen infusion von loesungen
DE102017114665A1 (de) Dosiereinrichtung u.a.
EP1163917A1 (fr) Dispositif de dialyse ayant une chambre d'equilibrage et procede de fonctionnement du dispositif de dialyse
DE112012006079T5 (de) Peritonealdialyse-Systeme, -Vorrichtungen und -Verfahren
EP3429544B1 (fr) Procede de fabrication d'une preparation medicamenteuse a l'aide d'une pompe tubulaire
WO2006125671A1 (fr) Dispositif et procede de transport de liquides medicaux
DE102007036816A1 (de) Verfahren und Vorrichtung zum Fördern von Lebensmitteln
DE102013015313A1 (de) Applikationsanlage und entsprechendes Applikationsverfahren
EP3466818A1 (fr) Module d'alimentation en fluide destiné à éliminer des bulles de gaz d'un trajet de fluide
WO2018134045A1 (fr) Diagnostic par capteur de mesure de la concentration de dialysat
DE3018205A1 (de) Verfahren zum dosieren von bindemitteln fuer die beleimung von spaenen, fasern o.dgl. fuer die spanplattenherstellung sowie vorrichtung zur durchfuehrung des verfahrens
DE10034368C1 (de) Dialysevorrichtung und Verfahren zum Betreiben einer Dialysevorrichtung
EP3290064B1 (fr) Systeme de mesure d'une quantite d'un liquide dans un sac plastique
EP3012014A1 (fr) Installation de traitement de liquide
EP3493861B1 (fr) Procédé pour surveiller la teneur en bicarbonate et la teneur en sodium d'un dialysat
DE102019101941A1 (de) Verfahren zum Überprüfen der Fördergenauigkeit von Fördermitteln einer medizinischen Behandlungsvorrichtung, und Vorrichtungen
DE102018121080A1 (de) Verfahren und Vorrichtung zur intermittierenden, pulsierenden Proportionierung einer Dialysierflüssigkeitsmischung

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181002

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20190920

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40002022

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20221109

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502017014633

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1560683

Country of ref document: AT

Kind code of ref document: T

Effective date: 20230515

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2945413

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20230703

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20230419

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230821

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230819

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230720

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502017014633

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20240122

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240129

Year of fee payment: 8

Ref country code: GB

Payment date: 20240129

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230419

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20240119

Year of fee payment: 8

Ref country code: MT

Payment date: 20240202

Year of fee payment: 8

Ref country code: IT

Payment date: 20240116

Year of fee payment: 8

Ref country code: FR

Payment date: 20240129

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240408

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20240118

Year of fee payment: 8

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL